CVS Slashes Profit Guidance Amid Rising Insurance Costs
CVS Health has significantly reduced its full-year profit forecast and announced a plan to cut $2 billion in expenses over several years. This comes as rising...
Kategori: Science
Merck Shares Fall 9% Despite Earnings Beat and Strong Demand for Key Drugs
Merck reported second-quarter revenue and adjusted earnings that exceeded Wall Street’s expectations, driven by strong sales from its blockbuster cancer drug Keytruda and other treatments in...
FDA Approves Guardant Health’s Blood Test for Colon Cancer Screening
The Food and Drug Administration (FDA) has approved Guardant Health’s blood test, Shield, for colon cancer screening. While not intended to replace colonoscopies, Shield is generating...